vs
Side-by-side financial comparison of FirstCash Holdings, Inc. (FCFS) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
FirstCash Holdings, Inc. is the larger business by last-quarter revenue ($501.3M vs $339.0M, roughly 1.5× HAEMONETICS CORP). FirstCash Holdings, Inc. runs the higher net margin — 20.8% vs 13.2%, a 7.6% gap on every dollar of revenue. On growth, FirstCash Holdings, Inc. posted the faster year-over-year revenue change (21.2% vs -2.7%). Over the past eight quarters, FirstCash Holdings, Inc.'s revenue compounded faster (16.9% CAGR vs 0.4%).
FirstCash Holdings, Inc. is an American pawnshop company headquartered in Fort Worth, Texas which operates retail pawn stores in the U.S. and Latin America. It is a publicly traded company listed on the Nasdaq stock exchange.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
FCFS vs HAE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $501.3M | $339.0M |
| Net Profit | $104.2M | $44.7M |
| Gross Margin | — | 59.7% |
| Operating Margin | 28.5% | 19.9% |
| Net Margin | 20.8% | 13.2% |
| Revenue YoY | 21.2% | -2.7% |
| Net Profit YoY | 24.7% | 19.3% |
| EPS (diluted) | $2.35 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $501.3M | $339.0M | ||
| Q3 25 | $411.0M | $327.3M | ||
| Q2 25 | $385.1M | $321.4M | ||
| Q1 25 | $371.1M | $330.6M | ||
| Q4 24 | $413.7M | $348.5M | ||
| Q3 24 | $363.1M | $345.5M | ||
| Q2 24 | $363.5M | $336.2M | ||
| Q1 24 | $366.8M | — |
| Q4 25 | $104.2M | $44.7M | ||
| Q3 25 | $82.8M | $38.7M | ||
| Q2 25 | $59.8M | $34.0M | ||
| Q1 25 | $83.6M | $58.0M | ||
| Q4 24 | $83.5M | $37.5M | ||
| Q3 24 | $64.8M | $33.8M | ||
| Q2 24 | $49.1M | $38.4M | ||
| Q1 24 | $61.4M | — |
| Q4 25 | — | 59.7% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 59.8% | ||
| Q1 25 | — | 58.4% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | — | 54.2% | ||
| Q2 24 | — | 52.0% | ||
| Q1 24 | — | — |
| Q4 25 | 28.5% | 19.9% | ||
| Q3 25 | 27.4% | 17.9% | ||
| Q2 25 | 21.1% | 16.8% | ||
| Q1 25 | 30.0% | 21.6% | ||
| Q4 24 | 26.5% | 16.9% | ||
| Q3 24 | 23.5% | 15.0% | ||
| Q2 24 | 18.2% | 11.8% | ||
| Q1 24 | 22.3% | — |
| Q4 25 | 20.8% | 13.2% | ||
| Q3 25 | 20.1% | 11.8% | ||
| Q2 25 | 15.5% | 10.6% | ||
| Q1 25 | 22.5% | 17.5% | ||
| Q4 24 | 20.2% | 10.8% | ||
| Q3 24 | 17.9% | 9.8% | ||
| Q2 24 | 13.5% | 11.4% | ||
| Q1 24 | 16.7% | — |
| Q4 25 | $2.35 | $0.95 | ||
| Q3 25 | $1.86 | $0.81 | ||
| Q2 25 | $1.34 | $0.70 | ||
| Q1 25 | $1.87 | $1.17 | ||
| Q4 24 | $1.86 | $0.74 | ||
| Q3 24 | $1.44 | $0.66 | ||
| Q2 24 | $1.08 | $0.74 | ||
| Q1 24 | $1.35 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $125.2M | $363.4M |
| Total DebtLower is stronger | $2.2B | $1.2B |
| Stockholders' EquityBook value | $2.3B | $911.5M |
| Total Assets | $5.3B | $2.5B |
| Debt / EquityLower = less leverage | 0.98× | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $125.2M | $363.4M | ||
| Q3 25 | $130.2M | $296.4M | ||
| Q2 25 | $101.5M | $292.9M | ||
| Q1 25 | $146.0M | $306.8M | ||
| Q4 24 | $175.1M | $320.8M | ||
| Q3 24 | $106.3M | $299.3M | ||
| Q2 24 | $113.7M | $344.4M | ||
| Q1 24 | $135.1M | — |
| Q4 25 | $2.2B | $1.2B | ||
| Q3 25 | $2.2B | $1.2B | ||
| Q2 25 | $1.7B | $1.2B | ||
| Q1 25 | $1.7B | $1.2B | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.7B | — | ||
| Q1 24 | $1.5B | — |
| Q4 25 | $2.3B | $911.5M | ||
| Q3 25 | $2.2B | $849.2M | ||
| Q2 25 | $2.1B | $882.3M | ||
| Q1 25 | $2.1B | $820.8M | ||
| Q4 24 | $2.1B | $906.9M | ||
| Q3 24 | $2.0B | $878.9M | ||
| Q2 24 | $2.0B | $905.4M | ||
| Q1 24 | $2.0B | — |
| Q4 25 | $5.3B | $2.5B | ||
| Q3 25 | $5.2B | $2.4B | ||
| Q2 25 | $4.5B | $2.5B | ||
| Q1 25 | $4.4B | $2.5B | ||
| Q4 24 | $4.5B | $2.5B | ||
| Q3 24 | $4.4B | $2.5B | ||
| Q2 24 | $4.3B | $2.5B | ||
| Q1 24 | $4.2B | — |
| Q4 25 | 0.98× | 1.34× | ||
| Q3 25 | 1.01× | 1.44× | ||
| Q2 25 | 0.79× | 1.39× | ||
| Q1 25 | 0.83× | 1.49× | ||
| Q4 24 | 0.85× | — | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 0.85× | — | ||
| Q1 24 | 0.75× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $206.6M | $93.6M |
| Free Cash FlowOCF − Capex | — | $87.2M |
| FCF MarginFCF / Revenue | — | 25.7% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | 1.98× | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | — | $308.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $206.6M | $93.6M | ||
| Q3 25 | $135.8M | $111.3M | ||
| Q2 25 | $116.9M | $17.4M | ||
| Q1 25 | $126.6M | $116.6M | ||
| Q4 24 | $198.1M | $43.8M | ||
| Q3 24 | $113.1M | $48.8M | ||
| Q2 24 | $106.2M | $-27.4M | ||
| Q1 24 | $122.5M | — |
| Q4 25 | — | $87.2M | ||
| Q3 25 | — | $106.3M | ||
| Q2 25 | — | $13.6M | ||
| Q1 25 | — | $100.9M | ||
| Q4 24 | — | $35.2M | ||
| Q3 24 | — | $39.4M | ||
| Q2 24 | — | $-33.1M | ||
| Q1 24 | — | — |
| Q4 25 | — | 25.7% | ||
| Q3 25 | — | 32.5% | ||
| Q2 25 | — | 4.2% | ||
| Q1 25 | — | 30.5% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | — | 11.4% | ||
| Q2 24 | — | -9.8% | ||
| Q1 24 | — | — |
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 1.7% | ||
| Q1 24 | — | — |
| Q4 25 | 1.98× | 2.09× | ||
| Q3 25 | 1.64× | 2.88× | ||
| Q2 25 | 1.95× | 0.51× | ||
| Q1 25 | 1.51× | 2.01× | ||
| Q4 24 | 2.37× | 1.17× | ||
| Q3 24 | 1.74× | 1.44× | ||
| Q2 24 | 2.16× | -0.71× | ||
| Q1 24 | 2.00× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FCFS
| US Pawn Segment | $292.2M | 58% |
| Retail POS Payment Solutions | $209.8M | 42% |
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
